Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Pengfei Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2165-6944; OpenAlex author ID A5101896978. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: 1 paper

Papers 5

  1. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.18632/oncotarget.9293↗
  2. Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway. Co-author DOI 10.1186/1471-2407-14-370↗
  3. Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro. First author DOI 10.1371/journal.pone.0114581↗
  4. Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action. Co-author DOI 10.1371/journal.pone.0063969↗
  5. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment. Co-author DOI 10.1016/s1499-3872(11)60073-8↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyou Wang · 5 shared papers, 2011–2016 · strength 0.24
  2. Tao Yin · 4 shared papers, 2011–2016 · strength 0.20
  3. Shanmiao Gou · 3 shared papers, 2013–2014 · strength 0.15
  4. Hengqiang Zhao · 1 shared paper, 2016 · strength 0.06
  5. Qingke Duan · 1 shared paper, 2016 · strength 0.06
  6. Zhengle Zhang · 1 shared paper, 2016 · strength 0.06
  7. Feng Zhou · 1 shared paper, 2014 · strength 0.05
  8. Zhu Zhu · 1 shared paper, 2011 · strength 0.03
  9. Yuan Tian · 1 shared paper, 2011 · strength 0.03
  10. Hong-Ji Wei · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.